5. References
- DRUGDEX® System (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu/. Accessed March 23, 2022.
- Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2020. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed March 23, 2022.
- Albuterol sulfate inhalation solution 0.083% package insert. Nephron Pharmaceuticals Corp., August 2018.
- Albuterol sulfate inhalation solution 0.5% package insert. Nephron Pharmaceuticals Corporation, February 2007.
- Albuterol sulfate solution 0.63 mg/3 ml, 1.25 mg/3 ml package insert. Mylan Pharmaceuticals, Inc., October 2021.
- Levalbuterol inhalation solution (Xopenex®) package insert. Akorn, Inc., February 2022.
- Arformoterol inhalation solution (Brovana®) package insert. Sunovion Pharmaceuticals Inc., May 2021.
- Formoterol inhalation solution (Perforomist®) package insert. Mylan Specialty, May 2019.
- Revefenacin inhalation solution (Yupelri®) package insert. Mylan Specialty LP, November 2021.
- Glycopyrrolate inhalation solution (Lonhala Magnair®) package insert. Sunovian Pharmaceuticals Inc., August 2020.
- Ipratropium bromide inhalation solution 0.02% package insert. Actavis Pharmaceuticals, Inc., April 2017.
- U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute. National Asthma Education and Prevention Program. Expert Panel 3: guidelines for the diagnosis and management of asthma. Full report 2007. NIH Publication No. 08-4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed March 23, 2022.
- Global Initiative for Asthma. Global strategy for asthma management and prevention, 2021 update. Available at: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf. Accessed March 23, 2022.
- Ipratropium bromide and albuterol sulfate inhalation solution package insert. Aurobindo Pharma Limited, June 2020.
- U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute. National Asthma Education and Prevention Program. 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. Accessed March 23, 2022.
- Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. 2022 Report. Available at: https://goldcopd.org/2022-gold-reports-2/. Accessed March 23, 2022.